story of the week
Safety and Efficacy of the AZD1222 Vaccine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
N. Engl. J. Med 2021 Sep 29;[EPub Ahead of Print], AR Falsey, ME Sobieszczyk, I Hirsch, S Sproule, ML Robb, L Corey, KM Neuzil, W Hahn, J Hunt, MJ Mulligan, C McEvoy, E DeJesus, M Hassman, SJ Little, BA Pahud, A Durbin, P Pickrell, ES Daar, L Bush, J Solis, QO Carr, T Oyedele, S Buchbinder, J Cowden, SL Vargas, AG Benavides, R Call, MC Keefer, BD Kirkpatrick, J Pullman, T Tong, MB Isaacs, D Benkeser, HE Janes, MC Nason, JA Green, EJ Kelly, J Maaske, N Mueller, K Shoemaker, T Takas, RP Marshall, MN Pangalos, T Villafana, A Gonzalez-Lopez,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.